LobbyingAanem American Association of Neuromuscular and Electrodiagnostic Medicine lobbying by quarter
Aanem American Association of Neuromuscular and Electrodiagnostic Medicine's latest lobbying report covers Q2 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $12.4K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Aanem American Association of Neuromuscular and Electrodiagnostic Medicine
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $12.4K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $12K | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $12K | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $12K | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $12.4K | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$24.2K · 15 reports
- Medicare and Medicaid$24.2K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)15 reports
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAanem American Association of Neuromuscular and Electrodiagnostic Medicine | $48.4K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/13for Q2 | In-house | Under $5,000 |
| 06/02for Q1 | In-house | $12.4K |
| 03/04for Q4 2025 | In-house | Under $5,000 |
| 01/20for Q4 2025 | In-house | Under $5,000 |
| 25/10/16for Q3 2025 | In-house | Under $5,000 |
| 25/07/22for Q2 2025 | In-house | Under $5,000 |
| 25/05/06for Q1 2025 | In-house | $12K |
| 25/02/06for Q4 2024 | In-house | Under $5,000 |
| 24/10/16for Q3 2024 | In-house | Under $5,000 |
| 24/07/16for Q2 2024 | In-house | $12K |
| 24/04/18for Q1 2024 | In-house | Under $5,000 |
| 24/01/15for Q4 2023 | In-house | Under $5,000 |
| 23/10/17for Q3 2023 | In-house | $12K |
| 23/08/28for Q2 2023 | In-house | Under $5,000 |
| 23/06/06for Q1 2023 | In-house | Under $5,000 |
| 23/01/16for Q4 2022 | In-house | Under $5,000 |